Skip Nav Destination
Issues
Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment
Yuwaraj Kadariya; Eleonora Sementino; Maggie Ruan; Mitchell Cheung; Parham Hadikhani; Hatice U. Osmanbeyoglu; Andres J. Klein-Szanto; Kathy Cai; Joseph R. Testa
Actívatexto: Feasibility and Acceptability of a Mobile Intervention That Promotes Smoking Cessation and Physical Activity among Latinos
Daimarelys Lara; Edgar I. Alaniz-Cantú; Simran Siddalingaiaha; Igor Oliveira; Arlette Chávez-Iñiguez; Elisa DeJesus; Daniel Fuller; David X. Marquez; Elizabeth Vásquez; Dongmei Li; Scott McIntosh; Deborah J. Ossip; Ana Paula Cupertino; Francisco Cartujano-Barrera
The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
Hadas Ashkenazi-Preiser; Or Reuven; Atara Uzan-Yulzari; Sharon Komisarov; Roy Cirkin; Sondra Turjeman; Carmel Even; Nira Twaik; Kerem Ben-Meir; Ivan Mikula, Jr; Leonor Cohen-Daniel; Yaron Meirow; Eli Pikarsky; Yoram Louzoun; Omry Koren; Michal Baniyash
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors
Mark Yarchoan; John D. Powderly; Bruno R. Bastos; Thomas B. Karasic; Oxana V. Crysler; Pamela N. Munster; Meredith A. McKean; Leisha A. Emens; Yvonne M. Saenger; Yasser Ged; Robert Stagg; Steven Smith; Chan C. Whiting; Anne Moon; Peppi Prasit; Yonchu Jenkins; Nathan Standifer; Thomas W. Dubensky; Sam H. Whiting; Susanna V. Ulahannan
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer
Elizabeth C. Wescott; Xiaopeng Sun; Paula Gonzalez-Ericsson; Ann Hanna; Brandie C. Taylor; Violeta Sanchez; Juliana Bronzini; Susan R. Opalenik; Melinda E. Sanders; Julia Wulfkuhle; Rosa I. Gallagher; Henry Gomez; Claudine Isaacs; Vijaya Bharti; John T. Wilson; Tarah J. Ballinger; Cesar A. Santa-Maria; Payal D. Shah; Elizabeth C. Dees; Brian D. Lehmann; Vandana G. Abramson; Gillian L. Hirst; Lamorna Brown Swigart; Laura J. van ˈt Veer; Laura J. Esserman; Emanuel F. Petricoin; Jennifer A. Pietenpol; Justin M. Balko
Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer
Hanna Grauers Wiktorin; Ebru Aydin; Roberta Kiffin; Caroline Vilhav; Johan Bourghardt Fagman; Mustafa Kaya; Sanchari Paul; Beatrice Westman; Svein Olav Bratlie; Peter Naredi; Kristoffer Hellstrand; Anna Martner
Modeling Myeloma Dissemination In Vitro with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics
Martin Kuric; Susanne Beck; Doris Schneider; Wyonna Rindt; Marietheres Evers; Jutta Meißner-Weigl; Sabine Zeck; Melanie Krug; Marietta Herrmann; Tanja Nicole Hartmann; Ellen Leich; Maximilian Rudert; Denitsa Docheva; Anja Seckinger; Dirk Hose; Franziska Jundt; Regina Ebert
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors
Benjamin Garmezy; Mitesh J. Borad; Rastilav Bahleda; Cesar A. Perez; Li-Tzong Chen; Shumei Kato; Do-Youn Oh; Paul Severson; Betty Y. Tam; Cheng S. Quah; James J. Harding
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds